Do you remember #TopNephrology stories in 2023? 👇Here is the recap 💡 #NephSky #MedSky any proposals for 2024? www.nephjc.com/news/2024/1/... - ThreadSky

nephjc.bsky.social • 88 days ago

Do you remember #TopNephrology stories in 2023? 👇Here is the recap

💡 #NephSky #MedSky any proposals for 2024?

http://www.nephjc.com/news/2024/1/15/top-stories-in-nephrology-2023

Comments

rnflex.bsky.social•88 days ago

This small supplemental article is probably gonna be super important as multi agonists drugs targeting GLP 1 and Glucagon progress through clinical trials but it might be 2025 before we learn more

https://diabetesjournals.org/diabetes/article/73/Supplement_1/319-OR/155526/319-OR-Renoprotective-Effects-of-Glucagon-and

rnflex.bsky.social•88 days ago

So much so that I imagine this presentation from EASD on retatrutide increasing GFR by 7-10ml/min is probably related to that renoprotective effect and may be occuring in the macula densa. More data to come in 2025...

divyaveerssneph.bsky.social•88 days ago

In the list of top stories from 2024

I'll add entities from Podocytopathies...

We could have a serological test for podocytopathies in the near future !

Anti Nephrin
Anti Slit diaphragm Ab

#Topnephrology #Nephsky
#Medsky

kidneyboy.bsky.social•88 days ago

New KDIGO CKD Guidelines! 2012 to 2024...too long for a fast moving field like nephrology

kidneyboy.bsky.social•88 days ago

Daprodustat being pulled from the market, the (near) final gasp of the HIF-PHIs

kidneyboy.bsky.social•88 days ago

FLOW!

kidneyboy.bsky.social•88 days ago

I think the mass migration from X to Bluesky counts.

kidneyboy.bsky.social•88 days ago

What about Ayus’ hyponatremia speed of correction meta-analysis showing that Seethapathy’s findings were not a fluke but reflect a real phenomena. Time for a prospective randomized trial.

https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2826087

raghumnephdoc.bsky.social•88 days ago

How did FLOW not make it?

nephroseeker.medsky.social•88 days ago

These are #TopNephrology stories for 2023. Now we gather the relevant ones from 2024 😀

raghumnephdoc.bsky.social•87 days ago

Cool! So these are already more than a year old!

nephroseeker.medsky.social•88 days ago

ApoE in C3 GN

http://www.nephjc.com/news/apoe-in-c3g-ddd

nephroseeker.medsky.social•88 days ago

PRAECIS trial, sFLT1: PIGF ratio in preeclampsia

Nominated last year, but didn’t make it to top 10. Now we, nephrologists, understand it better 👇👇👇

http://www.nephjc.com/freelyfiltered/2024/freely-filtered-70b-do-over-preeclampsia

ferarceamare.bsky.social•88 days ago

GLP-1

hswapnil.medsky.social•88 days ago

We could do an IgA Nephropathy - now with new drugs, almost every year for a while I think

#TopNephrology

hswapnil.medsky.social•88 days ago

Do we think the @asnkidney.bsky.social embrace of more clinical trials at #KidneyWk qualifies as a story?

(I am clearly conflicted!)

#TopNephrology

nephroseeker.medsky.social•88 days ago

I guess the celebration should be rather about getting more trials in nephrology. This was a necessary adjustmen (ERA also increased LBCT sessions from 2 to 4)

hswapnil.medsky.social•88 days ago

Yeah - ‘Nephrology meetings increasing LBCTs’ or
‘Renal orgs understanding RCT roles’

hswapnil.medsky.social•88 days ago

Intensive BP trials are winning
ESPRIT http://www.nephjc.com/news/esprit
BPROAD
also
2023 CHRCP https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02603-4/abstract
2021 STEP https://www.nejm.org/doi/full/10.1056/NEJMoa2111437
🇨🇳 RCTs
#TopNephrology

Posting Rules

Be respectful to others
No spam or self-promotion
Stay on topic
Follow Bluesky's terms of service

Comments

Posting Rules

Reply